Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines
Clinical trial NCT03481816 · COMPLETED
Trial details
- NCT number
- NCT03481816
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-24
- Primary completion
- 2020-01-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.